Summary
This prediction ended on 26.02.22 with a price of €50.75. With a performance of -2.82%, the BUY prediction for Bayer AG by Maleri closed slightly in the red. Maleri has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 5.546% | 5.546% | 64.274% | -31.844% |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% | 54.489% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% | 85.552% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% | 55.407% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% | 62.988% |
According to Maleri what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
EBIT growth > 30% per year expected
Leading role in innovation
Sustainability is very important
Growths much faster than the competition
Capable Management
Very small cyclical dependencies
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Medium risks for its business
Strong uniques
Very good company culture
Market Leader or Top 3
Well known brand
Cons
Comments by Maleri for this prediction
In the thread Bayer AG diskutieren
Buy Bayer AG